INVEST
Invest
Raise
Explore
Vault
Learn
Our Charter & Impact Report
Join the movement to fix capitalism
Careers
Help more founders take their shot
Knowledge Base
Fundraising & Investing, Explained
Blog
Latest news & updates
Press
Wefunder in the news
Help Center
FAQs and support
Log in or Sign Up
Explore
Vault
Learn
Our Charter & Impact Report
Join the movement to fix capitalism
Careers
Help more founders take their shot
Knowledge Base
Fundraising & Investing, Explained
Blog
Latest news & updates
Press
Wefunder in the news
Help Center
FAQs and support
Login or Sign Up
Simpli-Fi Automation, Inc.
Develop AI-powered medical diagnostic and human performance technologies using Breath Biomarkers
Last Funded July 2024
$0
raised
simplifiautomation.com
Saint Paul, MN
Overview
Details
Ask a Question
Highlights
1
We have a commercialization license to develop the NASA Electronic Nose for human medical use.
2
NASA e-Nose technology has been clinically proven to detect Covid-19 using breath. (Standford/NASA)
3
We are currently manufacturing our commercial beta prototype for pre-clinical validation.
4
Our technology has been selected for the Defense Innovation Unit Military Health Readiness Platform.
5
We have support from Samsung Electronics for integrating our sensor in Samsung phones and wearables.
6
We have been selected by the Cleveland Clinic to study using our e-nose technology to detect C-Diff.
7
We have been selected by the Mayo Clinic and NF1 Elite Athletic Training to study human performance.
8
Our team includes former vice presidents of 3M, Ford, Best Buy, Verizon, and Entegris Technologies.
Show more
Featured Investors
Team
Show More
Healthcare Ai meets the sense of Smell
Sources:
Arizton
,
MarketsandMarkets
,
Insights Partner
Downloads
Simpli-Fi Automation Deck-Provectus Breath Biomarker Diagnostics.pdf
Overview
Overview
Details
Posts
Ask a Question